Thuốc Benlysta

Thuốc Benlysta (Human Genome Sciences and GlaxoSmithKline) thử nghiệm trị bệnh Lupus Scheduled for a March 10 approval, Benlysta could be the first new lupus drug developed in 50 years. It isn't a cure. Taken monthly, the intravenous drug prevents flare-ups by inhibiting B-cells found in the immune system, which in lupus patients attack the body and organs. Lupus isn't easy to treat, which explains why Benlysta has received widespread attention and why Human Genome Sciences' stock price has skyrocketed over the last two years. ...